Lebenthal Global Advisors’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $664K | Buy |
14,340
+544
| +4% | +$25.2K | 0.12% | 119 |
|
|
2025
Q1 | $841K | Buy |
13,796
+119
| +0.9% | +$7.26K | 0.16% | 85 |
|
|
2024
Q4 | $774K | Buy |
13,677
+354
| +3% | +$20K | 0.14% | 102 |
|
|
2024
Q3 | $689K | Buy |
13,323
+2,178
| +20% | +$113K | 0.14% | 100 |
|
|
2024
Q2 | $463K | Buy |
11,145
+37
| +0.3% | +$1.54K | 0.1% | 121 |
|
|
2024
Q1 | $602K | Buy |
11,108
+218
| +2% | +$11.8K | 0.13% | 97 |
|
|
2023
Q4 | $559K | Buy |
10,890
+1,714
| +19% | +$87.9K | 0.13% | 101 |
|
|
2023
Q3 | $533K | Sell |
9,176
-732
| -7% | -$42.5K | 0.16% | 76 |
|
|
2023
Q2 | $634K | Sell |
9,908
-625
| -6% | -$40K | 0.18% | 58 |
|
|
2023
Q1 | $730K | Buy |
10,533
+156
| +2% | +$10.8K | 0.22% | 42 |
|
|
2022
Q4 | $747K | Buy |
10,377
+2,096
| +25% | +$151K | 0.25% | 36 |
|
|
2022
Q3 | $588K | Buy |
8,281
+472
| +6% | +$33.5K | 0.27% | 44 |
|
|
2022
Q2 | $601K | Buy |
+7,809
| New | +$601K | 0.29% | 55 |
|
|
2022
Q1 | – | Sell |
-8,136
| Closed | -$507K | – | 152 |
|
|
2021
Q4 | $507K | Buy |
+8,136
| New | +$507K | 0.21% | 76 |
|
|
2021
Q3 | – | Sell |
-15,150
| Closed | -$1.01M | – | 135 |
|
|
2021
Q2 | $1.01M | Buy |
+15,150
| New | +$1.01M | 0.54% | 24 |
|
|
2021
Q1 | – | Sell |
-5,195
| Closed | -$322K | – | 182 |
|
|
2020
Q4 | $322K | Buy |
+5,195
| New | +$322K | 0.23% | 59 |
|